Company: HCWB
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0000950170-25-072833
Chunk: 7

Company: HCW Biologics Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 6
Chunk 7
---
  
     011-40591  
     4.2  
     05/15/2025  

     10.10
     Form of Common Stock Warrant Purchase Agreement, dated May 13, 2025, between Company and Holder
     8-K  
     011-40591  
     4.1  
     05/15/2025  

     10.11
     Form of Common Stock Warrant, original issue date November 20, 2024, between Company and Holder, as amended
     8-K      
     011-40591     
     4.3     
     05/15/2025     

     31.1
     Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 

     X

     31.2
     Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 

     X

     32.1*
     Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

     X

     32.2*
     Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

     X

     101
     The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Balance Sheets as of December 31, 2024 and March 31, 2025 (unaudited); (ii) the Condensed  Statements of Operations for the three months ended March 31, 2024 (unaudited) and March 31, 2025 (unaudited); (